| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Procoagulant activity was demonstrated to activate prothrombin in rat uterus , to activate human coagulation factor 10 , and to cause clot formation by human plasma . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Activation of coagulation factor 10 by a complex of factors IXa VIIIa and prothrombin by a complex of factor Xa . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| It is shown that Echis carinatus venom activates both coagulation factor 2 and coagulation factor 10 . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| It did not hydrolyse casein , nor did it act on blood coagulation factor 10 , prothrombin and plasminogen . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Human prothrombin , blood coagulation factor 10 , and bovine osteocalcin were calculated to have 10 . 0 + / 0 . 7 , 11 . 0 + / 0 . 6 , and 2 . 1 + / 0 . 1 Gla residues per mole of protein , respectively , which agreed well with amino acid sequencing data . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Two metallo proteases , carinactivase and RVV 10 ( factor 10 activator of a snake venom ) , with C type lectin like domains , were isolated , characterized , and found to be useful in the study of the properties of prothrombin and coagulation factor 10 . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Structural comparison of venom prothrombin activator with blood coagulation factor 10 . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| In addition , BL MA was active in converting prourokinase , prothrombin , coagulation factor 10 , and protein C to their active forms . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Gene structures of trocarin D and coagulation factor 10 , two functionally diverse prothrombin activators from Australian rough scaled snake . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Vital signs , EKG tracings and laboratory parameters were monitored before and after the angiographic procedure ; the coagulation screening included : thrombin time , prothrombin time , partial thromboplastin time , euglobulin lysis time , plasma thromboplastin antecedent , and plasminogen activator inhibitor ( PAI ) . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| PBMC supernates did not contain fibrinogen , nor alter the thrombin , prothrombin , or partial thromboplastin times of normal plasma , amidolysis by activated plasma thromboplastin antecedent ( Factor XIa ) or activated Stuart factor ( Factor Xa ) or esterolysis by C 1 ( C 1 esterase ) ; they inhibited plasmin minimally . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| PGH also inhibited preparations of activated PTA ( Factor 11 ) and thrombin , and , when incubated with plasma , reduced the titer of coagulable fibrinogen , PTA Christmas factor ( Factor 9 ) , antihemophilic factor ( Factor 8 ) , Factor 7 , Stuart factor ( Factor 10 ) , proaccelerin ( Factor 5 ) and prothrombin ( Factor 2 ) , and to a lesser degres , HF . . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The present report on the Pt ( `` post transferrin ' ' approximately C 3 ) polymorphism represents the first report on the genetic variation of the corresponding beta1A globulin fraction within African Negroids ( PtA = 0 . 009 , PtB = 0 . 966 , PtC = 0 . 025 ) . . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Of 24 pTa tumours , 17 had substantial BGA expression and 7 were BGA ; 5 patients progressed , 4 substantially BGA positive and 1 BGA , all to category pT 1 ; 15 tumours were category pT 1 , 7 substantially BGA positive and 8 BGA ; 7 patients progressed , 1 substantially BGA positive and 6 BGA , all of whom died from bladder cancer ; 20 were pT 2 or deeper , 8 substantially BGA positive and 12 BGA ; 12 patients progressed , 6 substantially BGA positive and 6 BGA , all of whom died from bladder cancer . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| As for the stage , the 5 year survival rates for the patients with pTa , pT 1 , pT 2 , pT3a , pT3b , and pT 4 were 81 . 8 % , 64 . 7 % , 40 . 1 % , 30 . 5 % , 22 . 6 % and 6 . 7 % respectively . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The endocrine reactivity to a short term cold exposure ( + 4 degrees C during 1 h 30 min ) was studied in 8 full term ( FT ) and 12 preterm ( PT ) Limousin 10 Romanov lambs , obtained by oestrogen injections to the ewes ; 4 PT animals died ( PTD ) during the observation period and 8 remained alive ( PTA ) . ^^^ Moreover , the plasma T 4 levels rose slightly in FT animals ( + 12 % ) , increased sharply in PTA lambs ( + 137 % ) , or showed a small decrease in the PTD group ( 5 % ) in which a marked hypothermia occurred ; the relative changes in the circulating T 4 levels were positively related to the algebraic variations of rectal temperature in PT lambs . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Lamina propria microinvasion of bladder tumors , incidence on stage allocation ( pTa vs pT 1 ) : recommended approach . ^^^ We propose that in the assessment presented to the clinician , there should be a clear distinction between pTa tumors with a doubt as to microinvasion , microinvasive pT 1 tumors , and highly invasive pT 1 tumors . . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| It is recommended that clinicians employ an ascending procedure to measure SRTs and a descending procedure to measure PT thresholds to maximize the effectiveness of a screening test for pseudohypacusis based on PTA SRT differences . . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| There were also 8 p 53 positive cases in 21 low stage ( pTa , pT 1 ) tumors , and 21 in 26 high stage ( pT 2 4 ) tumors . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Significantly increased levels of thrombin antithrombin 3 complexes ( P < . 01 ) , prothrombin fragments 1 + 2 ( P < . 01 ) , and D dimers ( P < . 01 ) were found 1 hour , as well as 24 to 48 hours , after PTA . ^^^ Restenotic patients as a whole had higher plasma fibrinogen ( 3 . 46 + / 1 . 12 versus 2 . 95 + / 0 . 62 g / L , P < . 01 ) and C reactive protein ( 25 . 4 + / 46 . 7 versus 7 . 9 + / 6 . 9 mg / L , P < . 05 ) at baseline , as well as higher fibrinogen ( P < . 05 ) and prothrombin fragments 1 + 2 ( P < . 01 ) during months 3 to 6 after PTA . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| PURPOSE : To evaluate the treatment of grade 3 superficial ( stage pTa and pT 1 ) transitional cell carcinoma ( T . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The mutation was located within the pitA gene , which encodes the low affinity inorganic phosphate transport system ( Pit ) . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Sequence comparisons revealed that CysP , together with the phosphate permease of Neurospora crassa , Pho 4 , and E . coli PitA , belongs to the family of related transporters , the inorganic phosphate transporter ( Pit ) family . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| PTA was performed in all cases of TRAS in PT and in 19 AT . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Strain K 10 contains a nonfunctional pitA gene and lacks Pit activity when the Pst system is mutated . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| BACKGROUND AND PURPOSE : The purposes of this article are to describe the process of developing the physical therapist ( PT ) and physical therapist assistant ( PTA ) Clinical Performance Instruments ( CPIs ) and to present the available information on the psychometric properties of each instrument . ^^^ SUBJECTS : Two hundred seventeen PTA students and 282 PT students participated in the pilot studies of the CPIs , and 181 PTA students and 319 PT students participated in field studies . ^^^ METHODS : To construct each instrument , content was first gathered from a variety of instruments and American Physical Therapy Association documents related to PT and PTA practice and education . ^^^ RESULTS : Intraclass correlation coefficients ( ICC [ 2 , 1 ] ) measuring the interrater reliability of the CPI total score were good ( ICC= . 87 ) for the PT total score and moderate ( ICC= . 77 ) for the PTA total score . ^^^ DISCUSSION AND CONCLUSION : Sale of the fourth ( final ) versions of the PT CPI occurred in November 1997 and of the PTA CPI in March 1998 . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The serum LBP had positive correlation with prothrombin activity ( PTA ) ( r =0 . 395 8 , P < 0 . 01 ) , while it had no significant correlation with serum ALT and total bilirubin levels ( r =0 . 164 5 , 0 . 189 4 , respectively , P < 0 . 05 ) . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Other parameters such as ALT , total bilirubin ( TBil ) , albumin ( A ) and globulin ( G ) , gamma electrophoretic protein ( gamma EP ) , prothrombin activity ( PTA ) were also measured . 21 of the 122 patients ( 17 . 2 % ) were found to have HEV superinfection and the remaining 101 were not . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The series of ( 1 , 4 butanediamine ) Pt ( 4 ) complexes of the type trans , cis [ PtA ( 2 ) Cl ( 2 ) ( 1 , 4 butanediamine ) ] ( A=hydroxo 9 , acetato 12 , trifluoroacetato 13 as axial ligands ) and trans [ PtA ( 2 ) ( malonate ) ( 1 , 4 butanediamine ) ] ( A=hydroxo 16 , acetato 17 , trifluoroacetato 18 ) were synthesized and characterized by IR , NMR and elemental analysis . ^^^ The trans , cis [ PtA ( 2 ) Cl ( 2 ) ( 1 , 4 butanediamine ) ] were prepared by acetylation or trifluoroacetylation of trans , cis [ Pt ( OH ) ( 2 ) Cl ( 2 ) ( 1 , 4 butanediamine ) ] . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The fatality rate increased gradually with the ratio of aspartic aminotransferase to alanine aminotransferase ( AST / ALT ) and serum total bilirubin ( TBil ) , appearance of deviation of TBil and ALT , decrease in prothrombin activity ( PTA ) , total cholesterol ( TC ) , cholinesterase and albumin ( Alb ) ( P < 0 . 001 ) . 4 . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| CHE and PTA decreased and PT increased among the patients with cirrhosis and hepatitis gravis ( all P < 0 . 05 or P < 0 . 01 ) . ^^^ RNIAF was positively correlated with CHE , PT , and PTA in patents with cirrhosis . ^^^ CHE , PT and PTA remained at low levels while RNIAF almost returned to its normal level in the convalescents of hepatitis gravis . ^^^ CONCLUSION : Low cost , easy to operate and with early change and stable results , RNIAF may be used as an important indicator to evaluate the severity of liver diseases . of CHE , PT / PTA . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The results of liver function , renal function , blood routine , prothrombin time ( PT ) , prothrombin time activity ( PTa ) before and after the treatment were analyzed . ^^^ Compared with those before the therapy , there were significant differences in aminotransferase , total bilirubin , direct bilirubin , PT , PTa and total protein level after treatment ( P < 0 . 05 or P < 0 . 01 ) . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| OBJECTIVES : To measure the plasma levels of urokinase plasminogen activator ( uPA ) , urokinase plasminogen activator receptor ( uPAR ) and plasminogen activator inhibitor 1 ( PAI 1 ) , and study the relationship between the plasma levels of uPA , PAI 1 and the serum albumin ( Alb ) , collagen type 4 ( CIV ) , the serum hyaluronic acid ( HA ) , prothrombin time ( PT ) and prothrombin activity ( PTA ) in patients with different stages of liver cirrhosis following chronic hepatitis B . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The data of liver function , renal function , blood routine test , prothrombin time ( PT ) and prothrombin activity ( PTa ) pre and post therapy were analyzed . ^^^ PT , the level of total serum protein decreased significantly and PTa increased significantly after plasma exchange therapy and plasma exchange plus hemoperfusion adsorption therapy ( P < 0 . 05 or P < 0 . 01 ) . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The clinical signs and symptoms , total bilirubin ( TBIL ) , serum ammonia , endotoxin TNF alpha , IL 6 and prothrombin activity ( PTA ) , cholinesterase ( CHE ) were recorded before , during and after treatment . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The structure of the title compound , [ Pt ( C ( 6 ) H ( 5 ) ) ( 2 ) ( C ( 6 ) H ( 12 ) N ( 3 ) P ) ( 2 ) ] or [ Pt ( Ph ) ( 2 ) ( PTA ) ( 2 ) ] ( where Ph is phenyl and PTA is 1 , 3 , 5 triaza 7 phosphaadamantane ) , is discussed . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Blood routine , urine routine , blood urea nitrogen ( BUN ) , blood creatinine ( Cr ) , blood ammonia , alpha fetoprotein ( AFP ) , electrolyte , alanine transaminase ( ALT ) , aspartate transaminase ( AST ) , serum total bilirubin ( TBIL ) , serum direct bilirubin ( DBIL ) , prothrombin time activity ( PTA ) , total protein ( TP ) and albumin ( ALB ) were detected in the patients before treatment , 2 weeks after treatment , and at the end of the treatment . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| BACKGROUND : To investigate the effect of Oxymatrine ( OM ) on serum cholinesterase ( ChE ) during the treatment of viral hepatitis and the relationship between the change of ChE and the change of albumin ( ALB ) , prothrombin activity ( PTA ) and other liver function tests . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The purpose of this study was to compare computer assisted instruction ( CAI ) use in physical therapist ( PT ) and physical therapist assistant ( PTA ) education programs . ^^^ Questionnaires were mailed to 389 PT and PTA programs . ^^^ Eight percent of PT and 35 % of PTA programs indicated that all faculty are using CAI , whereas 3 % of PT and 6 % of PTA reported that no faculty are using CAI . ^^^ PT program respondents indicated using nine different types of CAI , whereas PTA programs indicated using eight different types . ^^^ Fifty seven percent of PT and 33 % of PTA programs provide formal computer instruction . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| Prothrombin time activity percentage ( PTA ) , activated partial thromboplastin time , coagulation activity of factor 2 , 5 , 7 , 8 , 9 and 10 were detected with clotting assay . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The serum concentrations of PAF , lipopolysaccharide ( LPS ) and prothrombin activity ( PTA ) , total bilirubin , and serum creatinine were detected in patients combined with HRS and in patients without HRS in hospital at the term . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| The 5 year cancer specific survival rate was 100 % for pTa / is , 95 . 2 % for pT 1 , 69 . 4 % for pT 2 , and 43 . 8 % for pT 3 . ^^^ CONCLUSION : Our experience showed that patients with pTa / is and pT 1 tumors treated with radical surgery have excellent prognoses . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| GnT 5 was positive in 26 of 44 cases of pTa ( 60 % ) and in 5 of 16 of pT 1 ( 31 % ) disease . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| These patients mostly had been followed for superficial urothelial carcinoma ( UC ) confined to the mucosa and lamina propria ( pathologic tumor [ pT ] classification pTa , pT 1 , and pTis [ carcinoma in situ ] ) for a mean of 15 . 62 months ( range , 4 28 mos ) . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| We developed sets of allele specific PCR and InDel markers for nine rice blast resistance genes Piz , Piz t , Pit , Pik , Pik m , Pik p , Pita , Pita 2 , and Pib which are commonly used in Japanese blast resistance rice breeding programs . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| OBJECTIVE : The study purpose was to examine the relationship between state regulations of physical therapists ( PT ) and three dependent variables : physical therapist assistant ( PTA ) utilization more than 50 percent of the time during the treatment episode ( high PTA utilization ) , number of visits , and patient self reported functional health status ( FHS ) at discharge . ^^^ We evaluated regulations governing licensure of PTAs , PT / PTA ratio , frequency of PT re evaluation , and PTA supervision . ^^^ High PTA utilization and regulations requiring full time onsite supervision were associated with more visits , whereas regulation of PT / PTA ratio was associated with fewer visits . ^^^ |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P03951 and P00734 |
Pubmed |
SVM Score :0.0 |
| NA |
|